A Study to Test the Safety and Effectiveness of MK-0974 (Telcagepant) Co-administered With Ibuprofen or Acetaminophen in Patients With Migraines With or Without Aura (MK-0974-046)

NCT00758836 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

683

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: placebo
DRUG: ibuprofen
DRUG: acetominophen
DRUG: telcagepant

Sponsor

Merck Sharp & Dohme LLC